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Abstract
This Editorial introduces the thematic series on ‘Toward a New Psychiatry: Philosophical and Ethical Issues in
Classification, Diagnosis and Care’ http://www.biomedcentral.com/series/newpsychiatry.
Editorial
In the main, medicine has progressed substantially in
recent years due to technological advances that have
arguably enhanced methods to analyse research data,
improved diagnostic techniques, and enabled more
effective therapeutics. Such advancements are also being
employed increasingly in psychiatry; in particular, pro-
gress in neuroimaging and other neurophysiological
techniques, developments in behavioural sciences and
psychotherapies, and developments in psychiatric genet-
ics have all contributed to knowledge of mental illnesses.
However, we must ask if, and in what ways these devel-
opments actually have affected the science, practice and
clinical value of psychiatry. In addition, psychiatry is
also confronting increasing diversity in socio-cultural
values, norms and perspectives. The constructs of nor-
mality and abnormality, mental health and disorder, and
the need for varying types of preventive and therapeutic
interventions are undergoing iterative change. In part,
this is reflected in, and influenced by the fifth edition of
the Diagnostic and Statistical Manual (DSM-5)o ft h e
American Psychiatric Association, which upon release in
spring of 2013, is hoped to instantiate greater consis-
tency, and improve the ways that psychiatric disorders
are classified and diagnosed [1], and lead to a greater
conformity of psychiatric therapeutics. Yet, we must ask
how these changes will affect the profession and practice
on the world-stage, given an increasing trend toward
pluralisation, and a need to address multi-cultural values
and expectations about the nature of mental health and
goals of psychiatric practice. Thus, we posit that the
profession and practice of psychiatry is poised for evolu-
tion, and there is a need to review how current practices
should be regarded, revised, implemented, and
monitored.
Such re-assessment and revision will be important as
worldwide social changes prompt new challenges and
opportunities in psychiatric research and practice: inter-
national ethnic, religious and political beliefs and beha-
viours are becoming evermore prevalent, and the field is
gaining prominence in non-western nations such as
Japan, China and India. These changes necessitate
reflection and insight in the philosophical and scientific
bases of the profession, the ethical, legal, and social
implications, as well as questions and problems that
may be incurred through its articulation. Namely, how
will - and perhaps should - advances in neuroscience,
neurotechnology and genetics alter studies, concepts
and the practise of psychiatry? In what ways might the
DSM-5 affect the practical, ethical and legal aspects of
the field, and its role in society? How might psychiatric
diagnostic and therapeutic practices be best suited to
meet the contingencies of non-Western societies? What
specific constructs, paradigms, tools and techniques
might shape and define this future path?
This thematic issue, ‘Toward a New Psychiatry: Phi-
losophical and Ethical Issues in Classification, Diag-
nosis and Care’, addresses these questions, concepts,
problems and possible solutions from multi-disciplinary
perspectives. The issue begins with a paper by Shadia
Kawa and James Giordano that presents the historiogra-
phy of the DSM and posits the implications of both the
history of the DSM, and the potential of the DSM-5 to
affect the current and future canon and practice(s) of
psychiatry [2]. James Phillips and colleagues review what
they suggest to be six essential questions in psychiatric
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nostic schemas and concepts affect the scope and con-
duct of psychiatric care, and the social relevance of the
field [3]. In response to proposed changes in the DSM-
5, Morten Hesse discusses how revisions in the diagnos-
tic criteria for antisocial personality disorder might lead
to more accurate understanding, and improved thera-
peutics [4].
The use, utility and real value of the psychopharmaco-
logical (vs psychotherapeutic) approach to depression is
addressed in a point-counterpoint dialectic provided by
John Ioannidis, and John M Davis and colleagues, which
then raises important questions about the actual nature
of psychiatric disorder [5,6]. Indeed, this concept is the
focus of ongoing debate, as Somogy Varga notes in
offering a more naturally-based groundwork upon which
to structure constructs of psychiatric norms, and devia-
tion [7]. S. Nassir Ghamei offers a detailed discussion of
what he refers to as “nosologomania”,a n dq u e s t i o n s
trends toward excessive categorization in light of Karl
Jaspers’ critique of Emil Kraepelin’s approach to classifi-
cation - and diagnosis - of psychiatric states and condi-
tions [8]. An essay by Randolph M Nesse and Dan J
Stein addresses the validity of a genuinely medical
model for psychiatric nosology [9], which relates to
Tejas Patil and James Giordano’s examination of core
ontological assumptions of the medical model of psy-
chiatry, and an attempt to re-align psychiatric canon
with core features of this model that are sustainable
through a bio-psychosocial orientation to constructs of
neuroscience, normality, and culture [10]. In this vein,
Peter Zachar and Kenneth S Kendler address the cate-
gorisation of homosexuality, and describe how changing
constructs of science, society and medicine must be elu-
cidated and acknowledged when ascribing social values
to psychiatric nosologies, diagnoses and the ontological
and socio-legal effects such claims manifest [11].
As a result of advancements in the neurosciences, stu-
dies of brain-behaviour relationships have increasingly
become part of the psychiatric literature, as evidenced
by the application of neuroimaging tools, such as func-
tional magnetic resonance imaging (fMRI). But neuro-
technological approaches, while important, are not
without limitations, and like any tool, must be used in
ways that are technically correct, ethically sound, and
effective in practise. Kristina M Visscher and Daniel H
Weissman argue that advances in cognitive neuroscience
research can be facilitated by greater sharing of raw
fMRI data between researchers, thereby allowing effec-
tive comparison, syntheses and validation of research-
based information that can be translated into more
meaningful clinical diagnostics and therapeutics [12].
Studies of neurocognitive developmental disorders, and
addiction disorders, have also increased significantly in
recent years, leading to the re-addressing treatment
options to include novel approaches to cognitive beha-
vioural, and pharmacological treatments. Kevin M
Antshel and colleagues address recent advances in the
understanding and treatment of Attention Deficit
Hyperactivity Disorder (ADHD), and specifically discuss
the use of both tailored formulations of stimulant drugs
and cognitive behavioral interventions [13]. Daryl
Shorter and Thomas R Kosten review recent pre-clinical
studies and clinical trials in the treatment of cocaine
addiction and emphasize the potential for future thera-
peutic developments [14]. Discussion of attention and
addiction, and the use of psychoactive agents calls forth
the proverbial “treatment-enhancement’ debate, and
Dan J Stein approaches this point through a thorough
discussion of psychopharmacology and its potential to
alter, affect and augment human cognition, emotion and
behaviour [15].
While striving to define notions of technical rectitude,
and individual and social good are crucial to the practise
of any form of medicine, we must ask what new devel-
opments in the neurosciences, and changes in society
portend for the future of psychiatry, and its place in
contemporary cultures? Jennifer H Radden explicitly
deals with such issues in her examination of patient
rights, the nature, values and varied needs of mental
health consumers, and the ways that reconstructive cul-
tural semantics may influence clinical, ontological and
socio-legal distinctions relative and relevant to psychia-
tric care [16]. Explicating problems, and limitations, and
posing possible solutions is critical if psychiatry is to
evolve as a consistently viable discipline in current and
future society. Yet, implementing such change may
require re-evaluation of philosophical, theoretical and
economic impediments, as Nathan M Gerard elucidates
[17]. To be sure, these factors figure prominently into
any calculus that will determine the future of psychiatry.
Yet, it is important to understand that shifting scientific,
socio-economic, and even political realities will influence
the trajectories that psychiatry can and will assume.
Thus, as Alexander M Carson and Peter Lepping notes
[18], it will be important to ground psychiatry to the
ethical tenets of medicine - a practice in the literal
sense, as an exchange of good, defined by those in rela-
tionship - that is dedicated to both the technically right
and morally sound care of those patients that are the
moral subject of clinical responsibility. It is in this spirit
of better defining how science, technology and social
forces will affect - and be affected by - psychiatry, both
today and in the years to come.
The ideas and opinions detailed in these papers repre-
sent insights to the ways that changing conceptualisa-
tions of mental function, health, disorder and illness
inform and direct the current and future practices of
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to publish important articles which address these issues,
and invite you to submit your manuscript to this cross-
journal, thematic series (edited by James Giordano, Edi-
tor-in-Chief of Philosophy, Ethics, and Humanities in
Medicine). Submissions addressing these themes are
invited to the following journals for inclusion: BMC
Medicine; BMC Psychiatry; BMC Neuroscience;BMC
Neurology; Genome Medicine and Philosophy, Ethics,
and Humanities in Medicine.
The constructs and practices of psychiatry (and the
world stage upon which it which it will be enacted), will
be explored further in a two-day conference: Towards a
New Psychiatry: Implications of Neuroscience, Neuro-
technology and the DSM-5, which will be held in
Washington, DC, USA, in April 2013 http://www.
toward-a-new-psychiatry.com/. The conference will
address these issues from multi-disciplinary perspectives,
and will bring together researchers, scholars, and clini-
cians to engage in discussion, debate and dialectic about
the historicity, canon, science, philosophy and ethics of
psychiatry as profession and practice, and what the field
can - and perhaps should - become.
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